Other headlinesNovel PET agent begins testingSiemens DR buoys charity
Merge unveils next gen web portal
Merge Healthcare unveiled today a zero-client software platform, FusionWeb, that promises to allow easy access by referring physicians to patient information, procedure reports and digital images. With FusionWeb, hospitals and imaging centers can include diagnostic images as part of a patient’s electronic medical record regardless of browser type, operating platform or security policies. The zero client software works without the need to install or maintain special visualization devices or software plug-ins. Anyone with a secured logon can access work lists and images, according to Merge. The new platform is based on Merge’s Cedara WebAccess technology. It can be bundled with the company’s Fusion RIS and PACS products.
Novel PET agent begins testing
Lantheus Medical Imaging has begun a Phase 1 clinical study to assess the safety, dosimetry, and tolerability of a novel PET radiotracer designed to identify patients at risk of fatal arrhythmia. The F-18 agent, dubbed LMI1195, is designed to visually indicate cardiac neuronal function. Done on healthy subjects, the Phase 1 study will attempt to estimate the radiation dosimetry of LMI1195, as well as evaluate the safety and patient tolerability of the tracer. Investigators will also gather pharmacokinetic and metabolic data, and assess PET imaging parameters and image quality.
Siemens DR buoys charity
Siemens’ donation of a digital radiography system has put $285,000 in the coffers of the Children’s Health Fund. Siemens donated a new Ysio to the Fund, which ran an online auction won by John T. Mather Memorial Hospital. The Port Jefferson, NY, hospital this week presented a check for its winning bid to the national organization dedicated to provide health care for homeless and medically disadvantaged children and advocating on behalf of all children.
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.